Publication | Open Access
Chimeric antigen receptors that trigger phagocytosis
30
Citations
29
References
2018
Year
Unknown Venue
ImmunologyImmunoeditingAntigen ProcessingImmunotherapeuticsCd4 T Cell ResponsesImmunotherapySynthetic ImmunologyTumor ImmunologyTumor ImmunityChimeric Antigen ReceptorsAutoimmune DiseaseWhole Cancer CellsCancer Cell EngulfmentAutoimmunityHumoral ImmunityT Cell ImmunityCancer CellsCell BiologyPhagocyteCancer ImmunosurveillanceImmune Effector FunctionsMedicine
Abstract Chimeric antigen receptors (CARs) are synthetic receptors that reprogram T cells to kill cancer. The success of CAR-T cell therapies highlights the promise of programmed immunity, and suggests that applying CAR strategies to other immune cell lineages may be beneficial. Here, we engineered a family of Chimeric Antigen Receptors for Phagocytosis (CAR-Ps) that direct macrophages to engulf specific targets, including cancer cells. CAR-Ps consist of an extracellular antibody fragment, which can be modified to direct CAR-P activity towards specific antigens. By screening a panel of engulfment receptor intracellular domains, we found that the cytosolic domains from Megf10 and FcRγ robustly triggered engulfment independently of their native extracellular domain. We show that CAR-Ps drive specific engulfment of antigen-coated synthetic particles and whole cancer cells. Addition of a tandem PI3K recruitment domain increased cancer cell engulfment. Finally, we show that CAR-P expressing macrophages reduce cancer cell number in co-culture by over 40%. Summary We report the first Chimeric Antigen Receptors for Phagocytosis (CAR-Ps) that promote engulfment of antigen-coated particles and cancer cells.
| Year | Citations | |
|---|---|---|
Page 1
Page 1